Cloning and characterization of the gene encoding mouse osteoclast differentiation factor

Gene

Volumn 230, Issue 1, 1999, Pages 121-127

  Kodaira, Kunihiko ^a   Kodaira, Koko ^a   Mizuno, Atsuko ^b   Yasuda, Hisataka ^b   Shima, Nobuyuki ^b   Murakami, Akihiko ^b   Ueda, Masatsugu ^a   Higashio, Kanji ^b  

^a YS New Technology Institute   (Japan)

^b SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

Gene structure; OCIF; Osteoclastogenesis; TNF family

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; GENETIC ANALYSIS; GENETIC ORGANIZATION; GROWTH REGULATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ANIMALS; BASE SEQUENCE; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CLONING, MOLECULAR; EXONS; INTRONS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; OSTEOCLASTS; PHYLOGENY; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RODENTIA;

EID: 0033119705     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00025-6     Document Type: Article

References (41)

1. Anderson D.M., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-179.
2. Banner D.W., et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell. 73:1993;431-445.
3. Breathnach R., Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem. 50:1981;249-383.
4. Browning J.L., et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell. 72:1993;847-856.
5. Bucay N., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1998;1260-1268.
6. Chambers T.J., Hall T.J. Cellular and molecular mechanisms in the regulation and function of osteoclasts. Vitamins and Hormones. 46:1991;41-86.
7. Chen C.-Y., Shyu A.-B. AU-rich elements: characterization and importance in mRNA degradation. Trends. Biochem. Sci. 20:1995;465-470.
8. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20:1992;3-26.
9. Freter R.R., Irminger J.C., Porter J.A., Jones S.D., Stiles C.D. A novel 7-nucleotide motif located in 3′ untranslated sequences of the immediate-early gene set mediates platelet-derived growth factor induction of the JE gene. Mol. Cell. Biol. 12:1992;5288-5300.
10. Horwood N.J., Elliott J., Martin T.J., Gillespie M.T. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 139:1998;4743-4746.
11. Lacey D.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165-176.
12. Lagnado C.A., Brown C.Y., Goodall G.J. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: the functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Mol. Cell. Biol. 14:1994;7984-7995.
13. Matsuzaki K., et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246:1998;199-204.
14. Mizuno A., Murakami A., Nakagawa N., Yasuda H., Tsuda E., Morinaga T., Higashio K. Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis. Gene. 215:1998;339-343.
15. Mizuno A., et al. Severe osteoporosis in mice lacking OCIF/OPG (Osteoclastogenesis inhibitory factor/Osteoprotegerin). Biochem. Biophys. Res. Commun. 247:1998;610-615.
16. Nedospasov S.A., Hirt B., Shakhov A.N., Dobrynin V.N., Kawashima E., Accolla R.S., Jongeneel C.V. The genes for tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) are tandemly arranged on chromosome 17 of the mouse. Nucleic Acids Res. 14:1986;7713-7722.
17. Nedospasov S.A., et al. Tandem arrangement of the genes encoding for tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β) in the human gene. Cold Spring Harbor Symposia on Quantitative Biology. 1986;611 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Nedwin G.E., Naylor S.L., Sakaguchi A.Y., Smith D., Jarrett-Nedwin J., Pennica D., Goeddel D.W., Gray P.W. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 13:1985;6361-6373.
19. Page R.D.M. TREEVIEW: An application to display phylogenetic trees on personal computers. Comput Appl. Biosci. 12:1996;357-358.
20. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271:1996;12687-12690.
21. Roodman G.D. Advances in bone biology: the osteoclast. Endocr. Rev. 17:1996;308-332.
22. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. 2nd ed. 1989;Cold Spring Harbor Press, Cold Spring Harbor, NY.
23. Shizuya H., Birren B., Kim U.J., Mancino V., Slepak T., Tachiiri Y., Simon M. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. Proc. Natl. Acad. Sci. USA. 89:1992;8794-8797.
24. Simonet W.S., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 89:1997;309-319.
25. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:1994;959-962.
26. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation: update 1995. Endocrine Reviews Monographs 4. 1995;266-270 The Endocrine Society, Bethesda, MD.
27. Suda T., Udagawa N., Takahashi N. Cells of bone: osteoclast generation. Bilezikian J.P., Raisz L.G., Rodan G.A. Principles of Bone Biology. 1996;87-102 Academic Press, San Diego, CA.
28. Suda T., Nakamura I., Jimi E., Takahashi N. Regulation of osteoclast function. J. Bone Miner. Res. 12:1997;869-879.
29. Takahashi N., Akatsu T., Udagawa N., Sasaki T., Yamaguchi A., Moseley J.M., Martin T.J., Suda T. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:1988;2600-2602.
30. Takahashi T., Tanaka M., Inazawa J., Abe T., Suda T., Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1994;1567-1574.
31. Tesselaar K., Gravestein L.A., van Schijndel G.M.W., Borst J., van Lier R.A.W. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159:1997;4959-4965.
32. Thompson J.D., Higgins D.G., Gibson T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
33. Tsitsikov E.N., Ramesh N., Geha R.S. Structure of the murine CD40 ligand gene. Mol. Immunol. 31:1994;895-900.
34. Tsuda E., Goto M., Mochizuki S., Yano K., Kobayashi F., Morinaga T., Higashio K. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234:1997;137-142.
35. Wiley S.R., et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
36. Wong B.R., et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:1997;25190-25194.
37. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., Choi Y. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:1997;2075-2080.
38. Xu N., Chen C.-Y., Shyu A.-B. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell. Biol. 17:1997;4611-4621.
39. Yasuda H., et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG-OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 139:1998;1329-1337.
40. Yasuda H., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95:1998;3597-3602.
41. Zubiaga A.M., Belasco J.G., Greenberg M.E. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15:1995;2219-2230.